Abacavir sulfate and lamivudine


Entry
D08775            Mixture   Drug                                   
Name
Abacavir sulfate and lamivudine;
Epzicom (TN)
Product
EPZICOM (ViiV Healthcare Company)
  Generic
ABACAVIR AND LAMIVUDINE (Aurobindo Pharma Limited), ABACAVIR AND LAMIVUDINE (Burel Pharmaceuticals), ABACAVIR AND LAMIVUDINE (Cadila Healthcare Limited), ABACAVIR AND LAMIVUDINE (Cipla USA), ABACAVIR AND LAMIVUDINE (Laurus Labs Limited), ABACAVIR AND LAMIVUDINE (Lupin Pharmaceuticals), ABACAVIR AND LAMIVUDINE (Zydus Pharmaceuticals (USA))
Component
Abacavir sulfate [DR:D00891], Lamivudine [DR:D00353]
Class
Antiviral
 DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR02
Product: D08775<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR02 Lamivudine and abacavir
      D08775  Abacavir sulfate and lamivudine <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Abacavir Sulfate/ Lamivudine
    D08775  Abacavir sulfate and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D08775  Abacavir sulfate and lamivudine
Drug groups [BR:br08330]
 Antiviral
  DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
   D08775  Abacavir sulfate and lamivudine
  DG03107  Anti-HIV agent
   D08775  Abacavir sulfate and lamivudine
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D08775  Abacavir sulfate and lamivudine
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D08775  Abacavir sulfate and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D08775
Other DBs
PubChem: 96025458